
Biogen
OrganizationHeard on podcasts recently
Biogen Inc. is a publicly traded American biotechnology company headquartered in Cambridge, Massachusetts, focused primarily on discovering, developing, and commercializing medicines for neurological and neurodegenerative diseases. The podcast references describe Biogen in that core context: its Alzheimer’s tau-focused drug research, partnerships such as a neurology collaboration with City Therapeutics, and its broader role as a major biopharmaceutical company; one market segment also refers to its stock under the ticker BIIB.
Rank this week
Share of the conversation
Reach this week
Tone this week
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Biogen per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 7 | 0.01‰ | 1 |
| Sep 22 | 0.03‰ | 3 |
| Oct 6 | 0.01‰ | 1 |
| Oct 7 | 0.02‰ | 1 |
| Oct 16 | 0.02‰ | 2 |
| Oct 20 | 0.03‰ | 1 |
| Oct 21 | 0.03‰ | 1 |
| Oct 23 | 0.02‰ | 1 |
| Oct 28 | 0.02‰ | 1 |
| Nov 2 | 0.02‰ | 1 |
| Nov 6 | 0.02‰ | 1 |
| Nov 20 | 0.01‰ | 1 |
Who is saying what about Biogen
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Justin Nielsen2 claims on 1 show
“the chart's not broken, I'm going to say this is still potentially actionable.”
Stock Market Today With IBD · Sep 22 ↗ - Dave Sekera1 claim on 1 show
“maybe now is a good time to at least take some of those profits off the table”
The Morning Filter · Nov 2 ↗
Discussed alongside
Names that come up in the same conversations as Biogen.
Embed this
Paste this on your site to show Biogen's current trend:
<iframe src="https://podlume.ai/embed/e/biogen" width="360" height="220" style="border:0" loading="lazy" title="Biogen on PodLume Trends"></iframe>